Home/Pipeline/Chimerism Monitoring

Chimerism Monitoring

Post-Allogeneic Stem Cell Transplantation Monitoring

CommercialActive

Key Facts

Indication
Post-Allogeneic Stem Cell Transplantation Monitoring
Phase
Commercial
Status
Active
Company

About BioType

BioType is a commercial-stage, private German diagnostics company specializing in molecular precision diagnostics for hemato-oncology and clinical research. Its business is built on a proprietary multi-biomarker testing platform (MODAPLEX) and a portfolio of CE-marked IVD kits for Acute Myeloid Leukemia (AML) profiling and chimerism monitoring post-transplant. The company is actively expanding its commercial reach through new distribution partnerships across Europe and is engaged in the local Saxony life sciences ecosystem, indicating a focus on growth and collaboration.

View full company profile

Therapeutic Areas